https://orcid.org/0000-0002-5210-179X
References
- Mondal SK, Mandal S. Prevalence of thalassemia and hemoglobinopathy in eastern India: a 10-year high-performance liquid chromatography study of 119,336 cases. Asian J Transfus Sci. 2016;10(1):105–110.
- Borgna-Pignatti C, Galanello R, et al. Thalassemias and related disorders: quantitative disorders of hemoglobin synthesis. In: Greer JP, Foerster J, Rodgers GM, editors. Wintrobe’s clinical hematology. 12th ed. Philadelphia (PA): Lippincott Williams and Wilkins. 2009:1082–1131.
- Cao A, Kan YW. The prevention of thalassemia. Cold Spring Harb Perspect Med. 2013;3(2):a011775.
- Khera R, Singh T, Khuana N, et al. HPLC in characterization of hemoglobin profile in thalassemia syndromes and hemoglobinopathies: a clinicohematological correlation. Indian J Hematol Blood Transfus. 2015;31(1):110–115.
- Old JM, Varawalla NY, Weatherall DJ. Rapid detection and prenatal diagnosis of β-thalassaemia: studies in Indian and Cypriot populations in the UK. Lancet. 1990;336(8719):834–837.
- Liu YT, Old JM, Miles K, et al. Rapid detection of alpha-thalassaemia deletions and alpha-globin gene triplication by multiplex polymerase chain reactions. Br J Haematol. 2000;108(2):295–299.
- Colah R, Italia K, Gorakshakar A. Burden of thalassemia in India: the road map for control. Pediatr Hematol Oncol J. 2017;2(4):79–84.
- Mukhopadhyay D, Saha K, Sengupta M, et al. Spectrum of hemoglobinopathies in West Bengal, India: a CE-HPLC study on 10407 subjects. Indian J Hematol Blood Transfus. 2015;31(1):98–103.
- Olivieri NF, Pakbaz Z, Vichinsky E. Hb E/beta-thalassaemia: a common & clinically diverse disorder. Indian J Med Res. 2011;134(4):522–531.
- Singha K, Fucharoen G, Sanchaisuriya K, et al. EE score: an index for simple differentiation of homozygous hemoglobin E and hemoglobin E-β0-thalassemia. Clin Chem Lab Med. 2018;56(9):1507–1513.
- Pornprasert S, Tookjai M, Punyamung M, et al. A formula to identify potential cases of β-thalassemia/HbE disease among patients with absent HbA, HbE >75% and HbF between 5 and 15%. Lab Med. 2019;50(2):158–162.
- Pornprasert S, Moriyama A, Kongthai K, et al. Detection of beta-thalassemia/hemoglobin E disease in samples which initially were diagnosed as homozygous hemoglobin E. Clin Lab. 2013;59(5–6):693–697.
- Sinha S, Black ML, Agarwal S, et al. Profiling β-thalassaemia mutations in India at state and regional levels: implications for genetic education, screening and counselling programmes. Hugo J. 2009;3(1–4):51–62.
- Rahman MM, Islam MM, Khan L. An atypical presentation and diagnostic dilemma of sickle cell disease. Bangabandhu Sheikh Mujib Medical Univ J. 2017;10(2):105–108.